Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Olink Bioscience's Proseek Multiplex CVD I 96x96

Premium

Olink Bioscience this week launched Proseek Multiplex CVD I 96x96, a new protein biomarker panel for cardiovascular disease.

According to Olink, its new multiplex immunoassay allows the analysis of 92 cardiovascular-related protein biomarkers across 96 samples simultaneously. The assay requires one microliter of sample is required. The panel contains known cardiovascular and inflammatory markers as well as a few exploratory proteins that serve as new cardiovascular markers.

Olink said that the new panel can be run on Fluidigm's BioMark HD System. Using the BioMark HD System with the Proseek Multiplex CVD I 96x96, a researcher can now obtain results for up to 9,216 reactions in just a few hours, the firm said.

BioArray News discussed the new panel and other company developments with its CEO Simon Fredriksson during a recent visit to the firm's base in Uppsala, Sweden (BAN 10/15/2013).

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.